The objective was to analyze if the inability to perform a maximal voluntary contraction (MVC) of the pelvic floor muscles (PFMs) in a first assessment can influence the severity of urinary incontinence symptoms in women.
The epidemiologic Study of Women’s Health Across the Nation (SWAN) includes urinary incontinence (UI) questionnaire items. We introduced an independently self-administered paper towel test (PTT-ISA; invention disclosure #2021-347) to objectively demonstrate UI.
It is unclear how compartment of pelvic organ prolapse (POP) impacts overactive bladder (OAB) symptom severity or improvement after POP surgery. We hypothesized that anterior and apical prolapse are more strongly associated with OAB symptoms than posterior compartment prolapse.
Parkinson’s disease (PD) is an incurable and progressive neurodegenerative disorder. People with PD also have increased muscle weakness and the typical symptoms of tremor, stiffness, slowness, balance problems and/or gait disorders.
To report the British Association of Urological Surgeon’s (BAUS) guidance on the assessment and management of female voiding dysfunction. A contemporary literature search was conducted to identify the evidence base.
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic condition with highly prevalent negative consequences on sexual health and quality of life. However, there is a lack of consensus regarding treatment options that improve sexual function in this population.
Device-related healthcare-associated infections (HAIs), such as catheter-associated urinary tract infections (CAUTIs) and central-line-associated bloodstream infections (CLABSIs), are largely preventable.
(UroToday.com) The Game-Changing session at the European Association of Urology’s (EAU) 2021 virtual annual meeting included a discussion by Dr. Alberto Breda of the phase 3 KEYNOTE-564 clinical trial. Dr. Breda notes that based on several failed tyrosine kinase inhibitor (TKI) trials, the EAU guidelines do not recommend adjuvant therapy (sorafenib, pazopanib, everolimus, girentuximab, axitinib, or sunitinib) […]
(UroToday.com) In this rapid-fire debate, the focus is on the optimal therapy for patients with cT0 disease after neoadjuvant chemotherapy. We have three debaters for this talk – Dr. Kamal Pohar arguing for cystectomy, Dr. Ananya Choudhury arguing for trimodal therapy, and Dr. Paolo Gontero arguing for observation/bladder sparing.
(UroToday.com) Dr. Ignacio Durán, a medical oncologist from Spain, provides an excellent state-of-the-art lecture on the current immunotherapy-based management of metastatic clear cell RCC and variant RCC. He provides a historical perspective, the current status of therapy, and what we can potentially achieve.
